---
title: "Claris Biotherapeutics, Inc. SEC filings"
url: https://altstreet.investments/edgar/1809726
kind: edgar-entity
publisher: AltStreet (https://altstreet.investments)
license: Public factual pages may be read, quoted and cited with attribution and a link. Bulk redistribution is not permitted.
---

# Claris Biotherapeutics, Inc.: SEC filings and what they report

| Field | Value |
| --- | --- |
| Entity | Claris Biotherapeutics, Inc. |
| CIK | 1809726 |
| Filing family | Form D |
| Total offering amount (as filed) | $121,477,910 |
| Total sold (as reported) | $55,737,646 |
| Investors (as reported) | 14 |

## Filings (8 on record, newest first)

| Date | Form | Family | SEC link |
| --- | --- | --- | --- |
| August 12, 2026 | D/A | Form D | https://www.sec.gov/Archives/edgar/data/1809726/000180972626000004/ |
| August 7, 2026 | D | Form D | https://www.sec.gov/Archives/edgar/data/1809726/000180972626000003/ |
| September 22, 2025 | D | Form D | https://www.sec.gov/Archives/edgar/data/1809726/000180972625000004/ |
| March 7, 2025 | D | Form D | https://www.sec.gov/Archives/edgar/data/1809726/000180972625000001/ |
| January 8, 2024 | D | Form D | https://www.sec.gov/Archives/edgar/data/1809726/000180972624000001/ |
| October 24, 2023 | D/A | Form D | https://www.sec.gov/Archives/edgar/data/1809726/000180972623000001/ |
| July 14, 2021 | D/A | Form D | https://www.sec.gov/Archives/edgar/data/1809726/000180972621000001/ |
| April 27, 2020 | D | Form D | https://www.sec.gov/Archives/edgar/data/1809726/000180972620000001/ |


## More

- Entity page (HTML, with events, parties and the platform record): https://altstreet.investments/edgar/1809726
- SEC EDGAR filing index: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001809726&owner=include&count=40
- Signal history, evidence passages and the entity graph are AltStreet Terminal features: https://altstreet.investments/terminal

---

Source page: https://altstreet.investments/edgar/1809726
Machine index: https://altstreet.investments/llms.txt
AltStreet reads what platforms, funds and issuers file with the SEC and what they tell investors, and publishes the difference. Figures are as filed or as captured on the date stated; nothing here is investment advice.
